Capital One National Association’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Capital One National Association’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,614	Closed	-$332K	–	537
2018 Q1	$332K	Sell	20,614 -596	-3%	-$11.8K	0.02%	412
2017 Q4	$402K	Sell	21,210 -870	-4%	-$15.8K	0.03%	385
2017 Q3	$311K	Buy	+22,080	New	+$200K	0.02%	437
2016 Q3	–	Sell	-31,660	Closed	-$208K	–	519
2016 Q2	$208K	Buy	+31,660	New	+$224K	0.02%	483

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital One National Association's SPPI Position: Q2 2018 in Review

Capital One National Association sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2018, closing a stake of 20,614 shares — an estimated $332K sold.

Capital One National Association first reported a position in SPPI in Q2 2016 and held it in 4 quarters. The position peaked at $402K in Q4 2017. 180 funds tracked by Wall St. Rank hold SPPI as of Q2 2018.

Capital One National Association reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
Capital One National Association sold 20,614 Spectrum Pharmaceuticals Inc shares in Q2 2018, an estimated $332K.
Capital One National Association first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 4 quarters.
Capital One National Association's Spectrum Pharmaceuticals Inc position peaked at $402K in Q4 2017.
180 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.